| Sharon A Bellonio, MS | |
|
22 Tompkins St, Waterbury, CT 06708-1417 | |
| (203) 754-5141 | |
| Not Available |
| Full Name | Sharon A Bellonio |
|---|---|
| Gender | Female |
| Speciality | Audiologist-hearing Aid Fitter |
| Location | 22 Tompkins St, Waterbury, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306931308 | NPI | - | NPPES |
| 2V1532 | Other | CT | HEALTHNET |
| 04731 | Other | CT | HEARUSA |
| 5617574 | Other | CT | AETNA |
| 246000 | Other | CT | CONNECTICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 000246 (Connecticut) | Primary |
| 237600000X | Audiologist-hearing Aid Fitter | 000246 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sharon A Bellonio, MS 22 Tompkins St, Waterbury, CT 06708-1417 Ph: (203) 754-5141 | Sharon A Bellonio, MS 22 Tompkins St, Waterbury, CT 06708-1417 Ph: (203) 754-5141 |
News Archive
AIDS Healthcare Foundation (AHF), the operator of the largest non-government HIV testing program in California, today praised the California Legislature for its passage of Assembly Bill 221, which cleared the Assembly on final concurrence (61-0) today and moves on to the Governor's desk. AB 221 updates and streamlines the training of counselors for rapid HIV testing by exempting persons administering finger stick rapid HIV tests from the requirement for certification as a limited phlebotomy technician (LPT). It is widely expected that Schwarzenegger will sign the bill.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area, today announced that detailed results from two Phase 3 clinical trials of the company's product Silenor® (doxepin) have been accepted for publication in peer-reviewed scientific journals.
The study, published in the September issue of the Annals of Otology, Rhinology and Laryngology, found that patients who received platelet gel reported an easier recovery than patients who received traditional packing to stop bleeding.
Centers for Disease Control and Prevention (CDC) Director Dr. Julie Gerberding announced today new goals and integrated operations that will allow the federal public health agency to have greater impact on the health of people around the world.
› Verified 4 days ago